News Grünenthal buys Valinor and constipation drug for $250m German pain medicines specialist Grünenthal has dipped another toe in the M&A waters with a $250 million agreement to buy US drugmaker Valinor Pharma.
Articles What doctors say about that Super Bowl OIC ad Daniel Ghinn examines the social media conversations around an advertisement for opioid-induced constipation that was aired during the final of the hugely popular American football championship
R&D Immune mediation, B-cell depletion, and female leadership – ... In a new pharmaphorum podcast, Aoife Brennan, CEO of Climb Bio, discusses the treatment of immune-mediated diseases.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face